Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin Reduced H2O2- and G2385R-LRRK2-Induced Neurodegeneration
Jinru Zhang, Kai Li, Xiaobo Wang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13

Showing 13 citing articles:

New Promising Therapeutic Avenues of Curcumin in Brain Diseases
Tarek Benameur, Giulia Giacomucci, Maria Antonietta Panaro, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 236-236
Open Access | Times Cited: 75
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 29
Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension
Kai Mao, Ruixuan Wang, Kateryna Karpoff, et al.
GeroScience (2025)
Open Access | Times Cited: 1
Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson’s disease in mice via modulating gut microbiota and short-chain fatty acids
Benchi Cai, Lifan Zhong, Qitong Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson’s disease
Matthew T. Keeney, Emily M. Rocha, Eric K. Hoffman, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 767
Closed Access | Times Cited: 7
Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis
Wei Zhang, Xiaoyu Dong, Rui Huang
Pharmacological Research (2023) Vol. 193, pp. 106787-106787
Open Access | Times Cited: 11
The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson’s Disease Model
Ruru Jia, Yanling Liu, Ke Shuai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3709-3709
Open Access | Times Cited: 6
Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases
F.-Q. Guo, Xiangnan Qin, Jian Mao, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5700-5700
Open Access | Times Cited: 1
The Parkinson’s disease-associated mutation LRRK2 G2385R alters mitochondrial biogenesis via the PGC-1α-TFAM pathway
Jian Xue, Jinbao Zhang, Jinru Zhang, et al.
Mitochondrion (2023) Vol. 73, pp. 10-18
Closed Access | Times Cited: 3
Uncovering the Early Events Associated with Oligomeric Aβ-Induced Src Activation
Sandra I. Mota, Lígia Fão, Patrícia Coelho, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1770-1770
Open Access | Times Cited: 3
15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity
Matthew T. Keeney, Eric K. Hoffman, Julie Weir, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protective effects of a novel bicyclic γ-butyrolactone compound against H2O2 or corticosterone-induced neural cell apoptosis
Ze Zhang, Xiaochong Li, Qishuai Zhuang, et al.
Brain Research (2024) Vol. 1842, pp. 149099-149099
Open Access
Curcuminoids with Antineurodegenerative Properties: Current Trends and Future Perspectives
Lucivania Rodrigues dos Santos, Adonias Almeida Carvalho, Mahendra Rai, et al.
(2023), pp. 101-125
Closed Access
Page 1

Scroll to top